Recursion Pharmaceuticals Inc vs Western Digital Corp — how do they compare? Recursion Pharmaceuticals Inc trades at $3.36 (market cap $1.81B), while Western Digital Corp trades at $449.8 (market cap $150.95B). The key difference: Western Digital Corp is far larger — about 83.4× Recursion Pharmaceuticals Inc's market cap, and Western Digital Corp pays a 0.14% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| RXRX | WDC | |
|---|---|---|
Market Cap | $1.81B | $150.95B |
Sector | Health | Technology |
52-Week High | $6.79 | $746.23 |
52-Week Low | $2.84 | $74.66 |
Enterprise Value | $1.33B | $150.42B |
Dividend Yield | — | 0.14% |
Trailing returns across standard periods
Latest headlines on both assets
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →